(19)
(11) EP 0 591 320 A1

(12)

(43) Date of publication:
13.04.1994 Bulletin 1994/15

(21) Application number: 92913077.0

(22) Date of filing: 03.06.1992
(51) International Patent Classification (IPC): 
A61K 35/ 14( . )
A61K 39/ 395( . )
C07K 1/ 00( . )
C07K 14/ 00( . )
C07K 14/ 52( . )
C07K 16/ 18( . )
C12N 5/ 10( . )
C12P 21/ 02( . )
G01N 33/ 577( . )
A61K 38/ 00( . )
A61P 37/ 06( . )
C07K 1/ 22( . )
C07K 14/ 435( . )
C07K 16/ 00( . )
C07K 16/ 24( . )
C12N 15/ 02( . )
G01N 33/ 53( . )
C12R 1/ 91( . )
(86) International application number:
PCT/US1992/004614
(87) International publication number:
WO 1992/021240 (10.12.1992 Gazette 1992/31)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

(30) Priority: 03.06.1991 US 19910709375

(71) Applicant: LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
La Jolla, CA 92037 (US)

(72) Inventor:
  • KIMISHIGE, Ishizaka
    La Jolla, CA 92037 (US)

(74) Representative: VOSSIUS & PARTNER 
Postfach 86 07 67
D-81634 München
D-81634 München (DE)

   


(54) SUPPRESSOR T-CELL HYBRIDOMA